Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
19.37
+0.58 (3.09%)
Sep 14, 2026, 3:00 PM CST

SHA:688393 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
45.5131.2795.1567.6890.91217.68
Trading Asset Securities
241.97234.3655.3352.56175.54419.42
Cash & Short-Term Investments
287.48265.63150.48120.25266.45637.1
Cash Growth
74.54%76.52%25.14%-54.87%-58.18%-24.67%
Accounts Receivable
164.76179.52242.84245.25239.03211.94
Other Receivables
2.792.244.374.264.194.06
Receivables
167.56181.76247.21249.51243.22216.01
Inventory
106.190.1284.4474.9763.0740.57
Prepaid Expenses
-0.352.541.932.123.99
Other Current Assets
11.6374.26207.58120.9220.2211.51
Total Current Assets
572.76612.13692.25567.57595.08909.17
Property, Plant & Equipment
225.26238.32298.53314.38327.04276.65
Long-Term Investments
271.55263.93241.91402.48373.5286.07
Goodwill
26.1826.1826.4626.4629.5229.52
Other Intangible Assets
32.6210.65.586.475.785.85
Long-Term Deferred Tax Assets
49.2345.7735.6327.6119.0412.69
Long-Term Deferred Charges
20.9237.4940.5532.3715.754.17
Other Long-Term Assets
51.452.9821.8122.5927.0641.56
Total Assets
1,2501,2871,3631,4001,3931,366

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
32.6933.7332.6837.1432.5949.76
Accrued Expenses
11.5831.6829.3930.6334.3128.14
Short-Term Debt
-0.157.321.214.37
Current Portion of Leases
-2.071.4923.262.54
Current Income Taxes Payable
5.251.470.883.022.12.11
Current Unearned Revenue
10.057.76.326.8212.728.32
Other Current Liabilities
8.496.566.449.5214.998.97
Total Current Liabilities
70.0483.3784.51110.33114.26106.84
Long-Term Leases
0.560.881.655.187.242.85
Long-Term Unearned Revenue
29.4626.9427.5428.1928.9429.89
Long-Term Deferred Tax Liabilities
14.8415.1513.371416.0813.34
Other Long-Term Liabilities
1.651.653.923.923.923.04
Total Liabilities
116.55127.98130.99161.63170.45155.96

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
93.5793.5793.5793.5793.3493.34
Additional Paid-In Capital
680.55718.78734.14749.14741.35733.87
Retained Earnings
363.18371.78428.16420.9394.29376.79
Comprehensive Income & Other
-0.23-0.16-0.12--0.38-
Total Common Equity
1,1371,1841,2561,2641,2291,204
Minority Interest
-3.7-24.53-24-25.31-6.275.72
Shareholders' Equity
1,1331,1591,2321,2381,2221,210
Total Liabilities & Equity
1,2501,2871,3631,4001,3931,366

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.533.110.4428.3924.812.39
Net Cash (Debt)
284.94262.53140.0491.86241.64624.71
Net Cash Growth
93.39%87.46%52.45%-61.99%-61.32%-26.13%
Net Cash Per Share
3.382.791.510.962.556.66
Filing Date Shares Outstanding
61.2593.5793.5793.5793.3493.34
Total Common Shares Outstanding
61.2593.5793.5793.5793.3493.34
Working Capital
502.72528.76607.74457.23480.81802.34
Book Value Per Share
18.5612.6513.4213.5013.1612.90
Tangible Book Value
1,0781,1471,2241,2311,1931,169
Tangible Book Value Per Share
17.6012.2613.0813.1512.7812.52
Buildings
-216.09256.64256.58238.97216.44
Machinery
-173.88168.4151.86141.86116.01
Construction In Progress
--0.740.1910.5610.99